Neurim wins the battle but not (yet) the war for innovators
This article was originally published in SRA
Executive Summary
Mike Snodin and Michael Pears argue that while the EU decision on supplementary protection certificates might be good news for companies that find new uses for "old" active ingredients, it raises more questions than it answers and leaves lingering uncertainty for many other companies.